Are advanced oxidation protein products potential uremic toxcomplex [2]. Likewise, activated MN also release these ins? Oxidative stress, defined as a disruption of the equilibrium compounds, although at much lower rates than PMN, between the generation of oxidants and the activity of antiand are mainly endowed with the production of the pooxidant systems, plays a significant role in the development tent pro-inflammatory cytokines IL1, TNF-␣, and IL-6. of the inflammatory syndrome associated with chronic renal
In addition to the formation of NADPH oxidasefailure and hemodialysis. In our recent work, the aim of which was to better characterize oxidative stress in dialysis patients, derived ROS, phagocytic cells have the capacity to prowe described the presence of oxidized protein products, which duce chlorinated oxidants via the myeloperoxidase we have termed advanced oxidation protein products (AOPP), (MPO) system, which, in the presence of chloride ions, in the plasma of dialysis patients and we proposed AOPP as converts H 2 O 2 into hypochlorous acid (HOCl Ϫ ). In hunew markers of oxidative stress and potential inflammatory mediators. AOPP represent an exquisite marker of phagocyte-mans, MPO is the sole enzyme capable of generating derived oxidative stress, and their role in the pathophysiology such microbicidally-chlorinated oxidants [3] . However, of chronic renal failure and dialysis-related complications might more recent work on MPO has clearly shown that MPO be of great importance. Regarding the mechanisms of generais implicated in the inflammatory process associated with tion of AOPP, we pointed out the importance of myeloperoxiatherosclerosis since MPO is detected in aortic atherodase and the subsequent generation of chlorinated oxidants, previously considered solely as microbicidal agents, in the formatous plaques, but not in normal aortae [4, 5] . mation of AOPP. Indeed, AOPP appear to act as true inflam-In the dialysis patient, the pro-inflammatory effects of matory mediators since they are able to trigger the oxidative these oxidants, proteases, and cytokines are reinforced burst and the synthesis of inflammatory cytokines in neutroby the uremia-associated defect in anti-oxidant systems phils, as well as in monocytes. Thus, it could be hypothesized that the AOPP, which arise from the reaction between chlori- [6] , anti-proteases [7] , and cytokine inhibitors [8] . Recent nated oxidants and plasma proteins, constitute new uremic studies have clearly demonstrated that inflammation, totoxins with pro-inflammatory effects. gether with malnutrition, largely contributes to the accelerated atherosclerosis process of uremia, which still represents the leading cause of mortality in HD patients [9] . The presence of a chronic inflammatory state, which is, to a large extent, induced by an oxidative stress subsequent to disruption of the natural balance between the DESCRIPTION OF ADVANCED OXIDATION generation of oxidants and the activity of anti-oxidant PROTEIN PRODUCTS IN UREMIA systems, has been widely documented in end-stage renal Until recently, biological evidence of oxidative stress disease patients on maintenance hemodialysis (HD) [1] .
in the dialysis patient in vivo relied almost entirely on The oxidative stress is commonly attributed to the recurthe measurement of lipid peroxidation by-products, such rent activation of polymorphonuclear neutrophils (PMN) as malondialdehyde and thiobarbituric acid reactive suband monocytes (MN) during blood passage through stances (TBARS), which, in general, poorly reflect the dialysis circuits, and subsequent generation of activated intensity of oxidative stress. The exquisite vulnerability complement components following contact with bioincomof proteins to ROS is now well documented such protein oxidative damage could reflect the dialysis-decrease AOPP levels, thus revealing that they are devoid of oxidant activity. However, the precise chemical associated oxidative stress, we were able to isolate and characterize dityrosine-containing protein cross-linking structure of plasma AOPP has still not been elucidated.
Our recent data indicate that in vivo plasma AOPP might products in the plasma of dialysis patients; these we designated as advanced oxidation protein products (AOPP) in not be identical to in vitro HOCl-treated plasma, and more complicated reactions might occur in vivo. Like reference to the well-established advanced glycation end products (AGEs), to which AOPP appeared to be closely AGEs, AOPP represent a generic name for oxidativelymodified proteins, especially via the myeloperoxidase related [11] . The formation of AGEs has been widely documented during diabetes and aging, and is thought system. The methodology to determine plasma AOPP is well characterized and several groups have now con-to be responsible for tissue degradation. The presence of increased plasma levels of AGEs has been observed firmed the high AOPP levels in HD patients [15] and in other oxidative stress-related pathologies [16] . This in dialysis patients, independent of diabetes [12] . Interestingly, the hypothesis that oxidative stress is implicated methodology relies on their spectrophometric properties, which are the absorbance at 340 nm in acidic condi-in AGEs formation might also be relevant to the uremic toxicity syndrome. We reported that the well-character-tions, as previously described. ized AGEs pentosidine accumulates with progression of
The plasma concentration of the toxin should be chronic renal failure in close relationship with neopterin, higher in uremic than in nonuremic patients a well-characterized monocyte activation marker.
We showed that increased levels of AOPP are already observed at an early stage of chronic renal failure (CRF), ARE AOPP UREMIC TOXINS?
and rise with the progression of uremia. Our previous The contribution of uremia to chronic inflammatory data have clearly shown that plasma levels of AOPP state has been suggested and numerous studies have were significantly higher in predialysis CRF patients than shown that both monocyte activation and defect in antiin control groups and culminated in HD patients. Among oxidant systems occur early in the course of chronic renal predialysis patients, an inverse relationship between failure and gradually increase with its progression to plasma AOPP and creatinine clearance (Ccr) levels was end-stage renal disease. Interest has focused on the role found. Interestingly, AOPP levels are closely related to of uremic toxins generated during the course of chronic plasma levels of monocyte activation markers such as renal failure, some of which have known effects on neuneopterin, TNF-␣, and its soluble receptors. There was trophil and monocyte functions. Among these, AGEs no correlation with IL-6 and no correlation with markers have been the focus of numerous studies. In the search of activated T cells (soluble IL-2 receptors) or B cells whether AOPP could act as a uremic toxin, we have (soluble CD23) [17] . spent some effort during the last 10 years to determine
The compound must be a chemical or biological agent if AOPP could meet the criteria that characterizes a capable of interacting with biological systems and uremic toxin, according to Vanholder et al [13] .
produce
a deleterious biological response The compound should be chemically identified, and
The study of the relationship between AOPP and neuaccurate quantitative analysis in biological fluids trophil oxidative metabolism showed that neutrophil should be possible basal NADPH oxidase activity (as measured by luci-Size exclusion chromatography of uremic plasma algenin-amplified chemiluminescence [CL]) was within the lowed us to isolate high-molecular-weight AOPP (600 range of controls, regardless of the stage of CRF in kD), which are protein aggregates, and low-molecularpredialysis patients, but was significantly increased in weight compounds (around 80 kD), with albumin as a HD patients. Likewise, neutrophil MPO activity (as meamain component. Isolation of the two main plasma fracsured by luminol-amplified CL) remained within the nortions containing the two distinct AOPP peaks [11] has mal range in predialysis patients, regardless of the degree been reproduced by other groups [14] . Biochemical charof CRF, but was markedly higher in HD patients. These acteristics allow us to consider AOPP as final cross-linkdata strongly suggest that neutrophil oxidative potential ing products of protein oxidation. Compared with conis involved in plasma AOPP formation. trols, AOPP were found at very high concentrations in
In vitro studies showed that AOPP could be generated the plasma of dialysis patients and were closely related by exposing proteins such as human serum albumin to dityrosine, a marker of protein oxidation. In vitro, (HSA) to oxidants, among which HOCl Ϫ was found to exposure of control plasma or purified plasma albumin be the most powerful. We have previously shown that to chlorinated oxidants triggered the formation of AOPP HSA-AOPP has the ability to trigger an oxidative burst in an oxidant concentration-dependent manner. Antiin neutrophils as well as in monocytes. Interestingly, the intensity of the respiratory burst is dependent on the oxidants such as ascorbic acid or glutathione did not level of protein oxidation. The respiratory burst was thickness (CCA-IMT) and CCA wall-to-lumen ratio in uremic patients. AOPP levels were also positively corretriggered by different preparations of AOPP obtained lated with ferritin levels and the dose of intravenous with various ratios of HSA/HOcl [17] . More recently, iron administered. Interestingly, there was no correlation we have shown that AOPP purified from uremic plasma between other oxidative stress markers, such as malonalso trigger the respiratory burst of normal neutrophils. dialdehyde (MDA), and with cardiovascular parameters. Recently, we observed that AOPP were potent stimuli These findings support the concept of a role of phagoin triggering interleukin-8 synthesis in neutrophils, as cyte-derived oxidative stress in the accelerated atheroshown in Fig. 1A . We were able to show by flow cytomesclerosis of uremic patients, which may be enhanced by try analysis that marked IL-8 synthesis occurs 12 hours usual recommended doses of intravenous iron [19]. This following AOPP stimulation, and that it is potentiated study points out the relevance of AOPP follow-up in the by GM-CSF. Interestingly, HSA-AOPP was also able to management of uremia patients in their assessment for trigger the synthesis of inflammatory cytokines in monocardiovascular risk factors. cytes, such as TNF-␣ (Fig. 1B) .
CONCLUSION High concentrations should be related to specific uremic syndroms that decrease or disappear
In conclusion, we propose that AOPP generated via when the concentration is reduced the MPO system could not only be exquisite markers of the oxidative stress, but also active mediators of the So far, no study has been performed to see whether inflammation associated with the uremic state. AOPP pharmacologic modulation of AOPP could improve the appear to meet the criteria of a novel uremic toxin. inflammatory state associated with uremia. However, we Neutrophils and monocytes, which could themselves amhave recently described that, in vitro, N-acetylcysteine plify the inflammatory process by increasing the neutrocould selectively decrease AOPP-induced respiratory phil recruitment via enhanced IL-8 synthesis and oxidant burst without any effect on zymosan-induced respiratory generation, appear to be elective targets of AOPP. These burst in purified neutrophils. This was observed both in observations lead us to propose that AOPP are key moleneutrophils from control groups and from hemodialyzed cules in the cross-talk between these two types of phagopatients [18] . This potential pathway for modulating an cytes. It is plausible that they make a large contribution AOPP-induced pro-inflammatory effect has yet to be to the immune dysregulation and inflammatory process explored in vivo.
in uremia. AOPP belong to the compounds that could play a role in the development of cardiovascular complications. In ACKNOWLEDGMENT a recent study, we observed a significant association of This work was supported by the Extramural Grant Program, Baxter Company.
plasma AOPP with common carotid artery intima-media
